Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Kingchem
301509
5
Hunan Er-kang Pharmaceutical
300267
CN Stock MarketDetailed Quotes
688788 Shenzhen Consys Science&Technology Co., Ltd.
- 69.00
- 0.000.00%
Not Open Apr 25 09:30 CST
7.30BMarket Cap-26.72P/E (TTM)
0.00High0.00Low0lotVolume0.00Open69.00Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)105.75MShares87.5052wk High3.45P/B7.30BFloat Cap21.2552wk Low82.80Limit Up105.75MShs Float177.14Historical High55.20Limit Down0.00%Amplitude20.51Historical Low--Dividend TTM--Avg Price0lotAsk--Div YieldTTM100Lot Size0lotBid
Shenzhen Consys Science&Technology Co., Ltd. Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | -10.28%1.18B | -45.11%735.19M | -10.55%1.21B | -11.33%1.3B | -11.59%1.31B | -12.92%1.34B | -15.01%1.35B | -9.22%1.47B | -16.91%1.48B | -9.73%1.54B |
| Notes receivable and accounts receivable | -20.89%560.71M | -20.36%590.48M | -7.26%665.14M | -7.70%656.19M | -5.03%708.79M | -5.30%741.47M | -17.64%717.21M | -14.79%710.91M | -8.88%746.32M | -18.11%782.96M |
| -Notes receivable | -0.86%56.39M | -36.34%39.49M | 71.33%57.46M | -10.53%34.09M | -35.61%56.88M | 10.58%62.03M | 86.60%33.54M | 19.33%38.11M | 109.70%88.33M | -3.03%56.09M |
| -Accounts receivable | -22.64%504.32M | -18.91%550.99M | -11.12%607.67M | -7.54%622.09M | -0.92%651.91M | -6.52%679.44M | -19.83%683.67M | -16.15%672.8M | -15.31%657.99M | -19.08%726.87M |
| Other receivables (including interest and dividends) | 10.06%7.5M | -2.27%6.65M | -21.23%7.3M | -17.88%6.17M | 1.45%6.81M | 13.34%6.8M | -64.01%9.27M | -69.80%7.51M | -15.67%6.72M | 21.22%6M |
| -Other receivable | ---- | -2.27%6.65M | ---- | -17.88%6.17M | ---- | 13.34%6.8M | ---- | -69.80%7.51M | ---- | 21.22%6M |
| Contractual assets | -8.43%538.09K | -18.82%538.09K | -12.01%603.38K | -15.18%587.61K | -21.43%587.61K | -11.36%662.85K | --685.72K | --692.74K | --747.84K | --747.84K |
| Advance payment | -7.08%36.04M | -51.49%18.89M | 17.74%45.7M | 1,398.31%45.63M | 1,769.20%38.79M | 478.59%38.93M | -4.31%38.81M | -93.17%3.05M | -90.27%2.08M | -70.54%6.73M |
| Inventories | -4.32%301.54M | -6.36%279.13M | -8.11%303.21M | -10.21%292.63M | -7.99%315.17M | -7.79%298.1M | 14.91%329.96M | 14.38%325.89M | 18.30%342.55M | 9.66%323.29M |
| Receivable financing | -15.00%6.73M | 3.30%9.93M | 96.02%12.21M | 22.06%6.62M | -4.05%7.92M | -1.31%9.61M | 7.40%6.23M | -52.97%5.42M | -48.80%8.25M | -45.11%9.74M |
| Non-current assets due within one year | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1.06M | ---- |
| Other current assets | 29.83%14.78M | 5,648.42%524.21M | 24.42%6.66M | 19.37%6.52M | -9.15%11.38M | -7.26%9.12M | 189.26%5.35M | -74.86%5.46M | -39.56%12.53M | -51.52%9.83M |
| Total current assets | -12.35%2.1B | -11.42%2.17B | -8.51%2.25B | -8.35%2.32B | -7.78%2.4B | -8.71%2.44B | -12.87%2.46B | -10.99%2.53B | -12.04%2.6B | -11.36%2.68B |
| Non Current assets | ||||||||||
| Fixed assets | ---- | -3.44%28.51M | ---- | 6.27%33.46M | ---- | 23.00%29.53M | ---- | 29.41%31.48M | ---- | -3.81%24.01M |
| Intangible assets | -10.59%8.48M | -55.62%7.63M | -66.94%8.69M | -75.83%8.7M | -79.79%9.49M | -65.81%17.19M | 74.51%26.28M | 140.47%35.99M | 254.20%46.96M | 338.80%50.27M |
| Goodwill | -32.62%10.63M | -32.62%10.63M | -37.29%15.77M | -37.29%15.77M | -37.29%15.77M | -37.29%15.77M | 45,530.73%25.15M | 45,530.73%25.15M | 45,530.73%25.15M | 45,530.73%25.15M |
| Long deferred expense | 32,505.04%27.05M | 28,915.56%26.96M | -38.71%63.05K | -35.29%73.01K | --82.96K | --92.92K | --102.88K | --112.83K | ---- | ---- |
| Deferred tax assets | 9.01%44.49M | 16.57%47.55M | 13.78%49.37M | 10.13%46.47M | 13.79%40.81M | 13.61%40.79M | 90.87%43.39M | 85.62%42.19M | 79.99%35.87M | 80.17%35.9M |
| Usufruct assets | 135.19%39.88M | -20.94%15.44M | -20.98%14.53M | -17.34%18.3M | -29.06%16.96M | -28.56%19.52M | 30.68%18.39M | 33.56%22.14M | 38.99%23.9M | 38.65%27.33M |
| Other non current assets | 271.30%3.3M | -55.45%2.29M | 722.95%7.83M | 74.80%992.7K | -43.06%887.53K | 86.16%5.14M | -61.90%951.22K | -68.97%567.91K | -30.62%1.56M | 83.38%2.76M |
| Total non current assets | 33.19%159.6M | 8.57%139M | -11.72%127.3M | -21.49%123.76M | -25.36%119.83M | -22.60%128.03M | 84.58%144.19M | 95.86%157.64M | 105.93%160.55M | 113.13%165.42M |
| Total assets | -10.18%2.26B | -10.43%2.3B | -8.69%2.38B | -9.12%2.44B | -8.81%2.52B | -9.52%2.57B | -10.25%2.61B | -8.05%2.69B | -9.01%2.76B | -8.24%2.84B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | ---- | -45.17%3.19M | --3.34M | --4.9M | 218.84%11.37M | 63.38%5.83M | ---- | ---- | --3.57M | --3.57M |
| Notes payable and accounts payable | 20.51%73.78M | 22.23%69.02M | 50.69%79.21M | 50.61%71.75M | 12.98%61.23M | -15.89%56.47M | -4.11%52.57M | -5.24%47.64M | -5.96%54.19M | -3.32%67.13M |
| -Notes payable | ---- | ---- | --675K | --4.57M | -94.93%542.2K | ---- | ---- | ---- | -60.60%10.69M | -61.23%13.24M |
| -Accounts payable | 21.58%73.78M | 22.23%69.02M | 49.40%78.54M | 41.03%67.18M | 39.50%60.68M | 4.78%56.47M | 22.76%52.57M | 29.82%47.64M | 42.67%43.5M | 52.73%53.89M |
| Contract liabilities | 77.06%17.22M | -6.82%7.26M | 204.57%7.11M | 301.25%16.26M | 320.61%9.72M | 335.88%7.79M | -43.17%2.33M | 227.40%4.05M | -36.09%2.31M | -72.57%1.79M |
| Advance receipts | ---- | ---- | ---- | ---- | ---- | ---- | --4.52M | ---- | ---- | ---- |
| Salaries payable | -3.74%15.86M | 61.61%28.04M | -10.11%18.7M | 5.45%18.2M | -1.77%16.48M | -32.57%17.35M | 25.99%20.8M | -18.81%17.26M | -13.23%16.77M | 4.30%25.73M |
| Taxs payable | 43.70%1.82M | 18.23%2.9M | 105.52%5.32M | -35.76%3.12M | -6.83%1.27M | 54.78%2.45M | 2.76%2.59M | 23.63%4.85M | 173.93%1.36M | -32.64%1.58M |
| Other payable (including interest and dividends) | -35.38%12.32M | -19.08%13.69M | 24.18%17.48M | 45.35%18.56M | 24.17%19.07M | -10.51%16.92M | 196.20%14.08M | 191.11%12.77M | 156.20%15.35M | 208.30%18.9M |
| -Other payable | ---- | -19.08%13.69M | ---- | 45.35%18.56M | ---- | -10.51%16.92M | ---- | 191.11%12.77M | ---- | 208.30%18.9M |
| Non current liabilities due within one year | 36.78%10.88M | -7.46%9.97M | 8.18%5.18M | -0.93%7.09M | -40.62%7.96M | -19.46%10.78M | -51.62%4.79M | -28.64%7.15M | 45.92%13.4M | 46.76%13.38M |
| Other current liabilities | -15.78%2.99M | 26.44%5.16M | --1.77M | --2.13M | 43.44%3.55M | 65.14%4.08M | ---- | ---- | 147.17%2.47M | 25.19%2.47M |
| Total current liabilities | 3.24%134.87M | 14.44%139.23M | 35.84%138.11M | 51.51%142M | 19.37%130.63M | -9.58%121.66M | 9.79%101.67M | 2.45%93.72M | 12.53%109.43M | 11.95%134.55M |
| Current liabilities | ||||||||||
| Estimate liabilities | -6.10%4.77M | -37.69%3.16M | -16.29%4.23M | -20.67%4.39M | -3.96%5.08M | -12.89%5.07M | -8.51%5.05M | -12.35%5.53M | -33.70%5.29M | -37.47%5.82M |
| Deferred tax liabilities | -27.92%536.78K | -25.26%584.26K | -10.50%708.11K | -14.02%721.02K | -20.23%744.69K | -17.57%781.74K | --791.14K | --838.61K | --933.56K | --948.36K |
| Lease liabilities | 211.32%28.45M | -35.63%5.72M | -35.65%8.37M | -31.18%10.72M | -14.28%9.14M | -36.29%8.89M | 269.33%13M | 195.50%15.58M | 28.15%10.66M | 40.25%13.95M |
| Total non current liabilities | 125.58%33.76M | -35.79%9.46M | -29.41%13.3M | -27.88%15.83M | -11.38%14.97M | -28.86%14.74M | 108.48%18.84M | 89.46%21.95M | 3.59%16.89M | 7.58%20.72M |
| Total liabilities | 15.82%168.63M | 9.01%148.69M | 25.64%151.41M | 36.45%157.83M | 15.26%145.6M | -12.16%136.4M | 18.57%120.51M | 12.24%115.67M | 11.24%126.32M | 11.34%155.27M |
| Shareholders equity | ||||||||||
| Paid-in capital | 0.00%105.75M | 0.00%105.75M | 0.00%105.75M | 0.00%105.75M | 0.00%105.75M | 0.00%105.75M | 0.00%105.75M | 0.00%105.75M | 40.00%105.75M | 40.00%105.75M |
| Capital reserve funds | -0.41%2.15B | -0.41%2.15B | -0.31%2.16B | -0.00%2.16B | 0.20%2.16B | 0.20%2.16B | 0.20%2.16B | 0.20%2.16B | -1.38%2.16B | -1.38%2.16B |
| Surplus reserve funds | 0.00%37.77M | 0.00%37.77M | 0.00%37.77M | 0.00%37.77M | 0.00%37.77M | 0.00%37.77M | 0.00%37.77M | 0.00%37.77M | 0.00%37.77M | 0.00%37.77M |
| Retained profit | -210.85%-143.52M | -146.54%-85.17M | -104.20%-8.7M | -83.82%43.21M | -60.26%129.47M | -52.62%183M | -58.96%207.09M | -48.66%267.01M | -47.82%325.82M | -41.34%386.26M |
| Less:Treasury stock | 0.96%37.42M | 7.13%37.42M | 87.51%37.42M | --37.06M | --37.06M | --34.93M | --19.96M | ---- | ---- | ---- |
| Shareholders equity without minority interests | -11.77%2.12B | -11.39%2.18B | -9.62%2.25B | -10.14%2.31B | -8.72%2.4B | -8.70%2.46B | -11.15%2.49B | -8.81%2.57B | -10.20%2.63B | -9.19%2.69B |
| Minority interests | 11.01%-22.17M | -4.35%-20.07M | -206.76%-25.78M | -882.28%-29.22M | -389.42%-24.91M | -1,391.01%-19.23M | -68.44%-8.4M | 22.69%-2.98M | 338.52%8.61M | 44.63%-1.29M |
| Total shareholder equity | -11.77%2.09B | -11.51%2.16B | -10.35%2.23B | -11.17%2.28B | -9.96%2.37B | -9.37%2.44B | -11.29%2.49B | -8.79%2.57B | -9.80%2.64B | -9.16%2.69B |
| Total liabilityies and equity | -10.18%2.26B | -10.43%2.3B | -8.69%2.38B | -9.12%2.44B | -8.81%2.52B | -9.52%2.57B | -10.25%2.61B | -8.05%2.69B | -9.01%2.76B | -8.24%2.84B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified opinion | -- | -- | -- | -- |
| Auditor | -- | -- | -- | -- | -- | Beijing Dahua International Accounting Firm (Special General Partnership) | -- | -- | -- | Beijing Dahua International Accounting Firm (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 9 20:29
Learning From Buffett: Investing Wisely Amid Market Volatility Triggered by Trump's Tariffs